Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Piramal Enterprises Ltd.

www.piramal.com

Latest From Piramal Enterprises Ltd.

AbbVie-Allergan in India – Brimming With Opportunities?

Allergan brings with it a market-leading ophthalmology franchise and promising prospects for Botox in India, opening up new avenues for growth for AbbVie, which so far has been measured compared with some multinational peers in the country.

Commercial Deals

IPA's Jain On The Journey So Far And Fires To Douse

Sudarshan Jain, the new secretary general of the Indian Pharmaceutical Alliance and ex-Abbott managing director, wears many hats, including that of a senior advisor with a private equity advisory firm. He recounts having “survived in different cultures” in his career and outlines the priorities in his new role, amid continuing questions around generic quality.

India Commercial

Amgen Fails To Block Cipla’s Generic Cinacalcet In US, And It May Change How Patent Settlements Are Drafted

Amgen is unlikely to succeed on the merits of its breach of contract claim, court says, concluding that Teva’s December launch of its noninfringing generic precludes the Sensipar marketer from seeking recovery for Cipla’s at-risk launch under the Amgen-Cipla settlement agreement.

Generic Drugs Legal Issues

Lower-Cost Competitors Hit Amgen's Blockbusters

Q1 revenue was roughly in line with expectations, but product sales were lower than consensus as multiple blockbusters faced generic competitors and biosimilars – a scenario the company prepared investors for earlier this year.

Sales & Earnings Biosimilars
See All

Company Information

  • Industry
  • Diversified
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Piramal Healthcare Ltd.
  • Nicholas Piramal India Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Piramal Enterprises Ltd.
  • Senior Management
  • Vivek Sharma, CEO, Pharma Solutions
    Rajesh Laddha, CFO
    Ajay G Piramal, Chmn.
    Vijay Shah, COO
  • Contact Info
  • Piramal Enterprises Ltd.
    Phone: (91) 22 309566666
    247 Business Pk, LBS Marg, Vikhroli (W)
    A Wing, 6th Fl.
    Mumbai, Maharashtra, 400083
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register